Multicenter Validation Study to Implement Plasma Epidermal Growth Factor Receptor T790M Testing in Clinical Laboratories

Natasha B. Leighl,Suzanne Kamel-Reid,Parneet K. Cheema,Janessa Laskin,Aly Karsan,Tong Zhang,Tracy L. Stockley,Tristan A. Barnes,Roxana A. Tudor,Geoffrey Liu,S. Owen,Jeffrey Rothenstein,Ronald L. Burkes,Mussawar Iqbal,Alan Spatz,Léon C. van Kempen,Iyare Izevbaye,David Laurence,Lisa W. Le,Ming-Sound Tsao

Multicenter Validation Study to Implement Plasma Epidermal Growth Factor Receptor T790M Testing in Clinical Laboratories

2020

PURPOSEPlasma detection of EGFR T790M mutations is an emerging alternative to tumor rebiopsy in acquired epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor resistance. Validation of ...

Keywords:

EGFR T790M
validation study
Epidermal Growth Factor Receptor T790M
Tyrosine-kinase inhibitor
Cancer research
Epidermal growth factor receptor
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations